Home > Insider Trading > Filing (0001209191-11-039834)

Filing Details

Accession Number:: 0001209191-11-039834
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-07-18 20:25:33
Reporting Period:: 2011-04-14

Filing Date:: 2011-07-18
Accepted Time:: 2011-07-18 19:25:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
802724	Insite Vision Inc	INSV	Pharmaceutical Preparations (2834)	943015807

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1409751	Coliseum Capital Management, Llc	767 Third Avenue 35Th Floor New York NY 10017		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-04-14	41,200	$0.91	9,685,673	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2011-04-18	36,050	$0.89	9,721,723	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2011-04-25	132,815	$0.80	9,854,538	No	4	P	Indirect	See Footnote
Common Stock	Acquisiton	2011-07-12	5,000,000	$0.00	14,854,538	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2011-07-12	2,000,000	$0.00	2,000,000	$0.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,000,000	2011-07-18	2016-07-18	No	4	P	Indirect

Footnotes

These securities are held directly by (a) Coliseum Capital Partners, L.P., an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser, and (b) Blackwell Partners, LLC ("Blackwell"), a separate account investment advisory client of CCM. Christopher Shackelton and Adam Gray manage CCM and CC. Each of Christopher Shackelton, Adam Gray, Blackwell, CCP, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.
This transaction was executed in multiple trades at prices ranging from $0.88 to $0.92. The reported price reflects the weighted average purchase price. The Reporting Person filing this report hereby undertakes to provide upon request by the SEC staff, Insite Vision, Inc. or a shareholder of Insite Vision, Inc. full information regarding the number of shares purchased at each separate price.
This transaction was executed in multiple trades at prices ranging from $0.87 to $0.92. The reported price reflects the weighted average purchase price. The Reporting Person filing this report hereby undertakes to provide upon request by the SEC staff, Insite Vision, Inc. or a shareholder of Insite Vision, Inc. full information regarding the number of shares purchased at each separate price.
This transaction was executed in multiple trades at a price of $0.80. The reported price reflects the weighted average purchase price. The Reporting Person filing this report hereby undertakes to provide upon request by the SEC staff, Insite Vision, Inc. or a shareholder of Insite Vision, Inc. full information regarding the number of shares purchased at each separate price.
On July 12, 2011, CCM purchased 5,000,000 unregistered shares of Common Stock and warrants to purchase 2,000,000 shares of Common Stock from the Issuer in a private placement transaction for a total purchase price of $3,000,000.